1109 related articles for article (PubMed ID: 25640693)
1. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
[TBL] [Abstract][Full Text] [Related]
2. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
Zouboulis CC; Bechara FG; Fritz K; Goebeler M; Hetzer FH; Just E; Kirsten N; Kokolakis G; Kurzen H; Nikolakis G; Pinter A; Podda M; Rosinski K; Schneider-Burrus S; Taube KM; Volz T; Winkler T; Kristandt A; Presser D; Zouboulis VA
J Dtsch Dermatol Ges; 2024 May; ():. PubMed ID: 38770982
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa.
González-López MA
Med Clin (Barc); 2024 Feb; 162(4):182-189. PubMed ID: 37968174
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa: an update.
Ingram JR
Clin Med (Lond); 2016 Feb; 16(1):70-3. PubMed ID: 26833521
[TBL] [Abstract][Full Text] [Related]
5. A review of surgical and reconstructive techniques for hidradenitis suppurativa.
Wong HS; Jiang JY; Huang SD; Zhu P; Ji X; Wang DG
Arch Dermatol Res; 2024 May; 316(6):270. PubMed ID: 38796609
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis Suppurativa Is Associated with Severe Sexual Impairment.
Krajewski PK; Strobel A; Schultheis M; Staubach P; Grabbe S; Hennig K; Matusiak L; von Stebut E; Garcovich S; Bayer H; Heise M; Kirschner U; Nikolakis G; Szepietowski JC
Dermatology; 2024; 240(2):205-215. PubMed ID: 38190809
[TBL] [Abstract][Full Text] [Related]
7. Inborn Errors of Immunity in Hidradenitis Suppurativa Pathogenesis and Disease Burden.
Colvin A; Petukhova L
J Clin Immunol; 2023 Aug; 43(6):1040-1051. PubMed ID: 37204644
[TBL] [Abstract][Full Text] [Related]
8. Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution.
Huynh FD; Damiani G; Bunick CG
Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534703
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa: a new, principle-centered paradigm for managing a dynamic disease.
Wyant WA; Manjaly P; Orlowski GM
Int J Dermatol; 2024 Jun; 63(6):701-703. PubMed ID: 38425315
[TBL] [Abstract][Full Text] [Related]
10. Insights into the Pathogenesis of HS and Therapeutical Approaches.
Rosi E; Fastame MT; Scandagli I; Di Cesare A; Ricceri F; Pimpinelli N; Prignano F
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572354
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Hidradenitis Suppurativa and Diet: An Update.
Belamarić M; Miše J; Bukvić Mokos Z
Acta Dermatovenerol Croat; 2023 Dec; 31(4):213-219. PubMed ID: 38651848
[TBL] [Abstract][Full Text] [Related]
12. Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): data, scores and phenotypes since 2015.
Heudens S; Sarkis AS; Daoud M; Daxhelet M; Benhadou F; Suppa M; Nobile L; Karama J; Njimi H; White JM; Del Marmol V
Dermatology; 2024 Apr; ():. PubMed ID: 38621365
[TBL] [Abstract][Full Text] [Related]
13. Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review.
Molinelli E; Gioacchini H; Marani A; Rizzetto G; Gambini D; De Simoni E; Offidani A; Simonetti O
Dermatol Ther (Heidelb); 2024 May; 14(5):1079-1091. PubMed ID: 38700645
[TBL] [Abstract][Full Text] [Related]
14. Initial steps towards developing a predictive algorithm of disease progression for hidradenitis suppurativa (HS): results from a Cox proportional hazard regression analysis on disease progression among a cohort of 335 Danish patients with HS.
Kjærsgaard Andersen R; Pedersen O; Eidsmo L; Jemec G; Saunte D
Br J Dermatol; 2024 May; 190(6):904-914. PubMed ID: 38169316
[TBL] [Abstract][Full Text] [Related]
15. Low referral rate of overweight/obese patients with hidradenitis suppurativa to weight-management services: a missed opportunity?
Khalil N; Hussain K; Patel NP
Clin Exp Dermatol; 2024 Mar; 49(4):383-385. PubMed ID: 38037674
[TBL] [Abstract][Full Text] [Related]
16. Editor's Highlights - June 2024.
Kemény L
Int J Dermatol; 2024 Jun; 63(6):695-696. PubMed ID: 38716643
[TBL] [Abstract][Full Text] [Related]
17. Anaemia in the Hidradenitis Suppurativa Population.
Farrugia F; Mintoff D; Pace NP
Arch Dermatol Res; 2024 May; 316(5):193. PubMed ID: 38775823
[No Abstract] [Full Text] [Related]
18. Real-world effectiveness and safety of the LAight-therapy in patients with hidradenitis suppurativa.
Strobel A; Schultheis M; Staubach P; Grabbe S; Mann C; Hennig K; Szepietowski JC; Matusiak L; Krajewski P; von Stebut E; Garcovich S; Bayer H; Heise M; Podda M; Kirschner U; Nikolakis G
J Dtsch Dermatol Ges; 2024 May; ():. PubMed ID: 38807028
[TBL] [Abstract][Full Text] [Related]
19. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
Wainman HE; Chandran NS; Frew JW; Garg A; Gibbons A; Gierbolini A; Horvath B; Jemec GB; Kirby B; Kirby J; Lowes MA; Martorell A; McGrath BM; Naik HB; Oon HH; Prens E; Sayed CJ; Thorlacius L; Van der Zee HH; Villumsen B; Ingram JR
Br J Dermatol; 2024 Mar; 190(4):510-518. PubMed ID: 37976235
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
